Resilience in the Face of the COVID-19 Crisis: A Prospective Cohort Study of Frontline Health Care Workers in New York City

Robert H. Pietrzak; Adriana Feder; Jordyn H. Feingold; Lauren A. Peccoralo; Jonathan A. Ripp

doi:10.4088/PCC.22br03342

Resilience in the Face of the COVID-19 Crisis: A Prospective Cohort Study of Frontline Health Care Workers in New York City

Robert H. Pietrzak, Adriana Feder, Jordyn H. Feingold, Lauren A. Peccoralo, Jonathan A. Ripp

Research output: Contribution to journal › Comment/debate

1 Scopus citations

Original language	English
Article number	22br03342
Journal	The primary care companion for CNS disorders
Volume	24
Issue number	5
DOIs	https://doi.org/10.4088/PCC.22br03342
State	Published - 2022

Access to Document

10.4088/PCC.22br03342

Cite this

@article{7a314b1156a445d29f8f12d02452d01e,

title = "Resilience in the Face of the COVID-19 Crisis: A Prospective Cohort Study of Frontline Health Care Workers in New York City",

author = "Pietrzak, {Robert H.} and Adriana Feder and Feingold, {Jordyn H.} and Peccoralo, {Lauren A.} and Ripp, {Jonathan A.}",

note = "Funding Information: Submitted: June 22, 2022; accepted August 19, 2022. Published online: October 4, 2022. Relevant financial relationships: Dr Pietrzak is a research consultant to the Office of Well-Being and Research at Icahn School of Medicine at Mount Sinai (ISMMS). Dr Feder is named co-inventor on an issued patent in the US, and several issued patents outside the US, filed by ISMMS for the use of ketamine as a therapy for PTSD; this intellectual property has not been licensed. Drs Feingold, Peccoralo, and Ripp report no relevant financial relationships. Funding/support: This study was supported by internal funding devoted to COVID-19–related projects from the Icahn School of Medicine at Mount Sinai. Preparation of this report was supported in part by the US Department of Veterans Affairs National Center for Posttraumatic Stress Disorder (Dr Pietrzak). Dr Feingold was funded by TL1 grant TR001434. Role of the sponsor: The funders had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; or decision to submit the manuscript for publication. Acknowledgments: The authors thank all the participants at Mount Sinai Hospital who participated in this study. They also acknowledge the COVID-19 Psychological Impact Study Team for their contributions to this project: Chi C. Chan, PhD; Carly A. Kaplan, BS; Halley Kaye-Kauderer, BA; Jaclyn Verity, MPH; Larissa Burka, RN; Alicia Hurtado, MD; and James W. Murrough, MD, PhD. The acknowledged individuals have no relevant financial relationships to disclose. Supplementary material: See accompanying pages.",

year = "2022",

doi = "10.4088/PCC.22br03342",

language = "English",

volume = "24",

journal = "The primary care companion for CNS disorders",

issn = "1523-5998",

publisher = "Physicians Postgraduate Press Inc.",

number = "5",

}

TY - JOUR

T1 - Resilience in the Face of the COVID-19 Crisis

T2 - A Prospective Cohort Study of Frontline Health Care Workers in New York City

AU - Pietrzak, Robert H.

AU - Feder, Adriana

AU - Feingold, Jordyn H.

AU - Peccoralo, Lauren A.

AU - Ripp, Jonathan A.

N1 - Funding Information: Submitted: June 22, 2022; accepted August 19, 2022. Published online: October 4, 2022. Relevant financial relationships: Dr Pietrzak is a research consultant to the Office of Well-Being and Research at Icahn School of Medicine at Mount Sinai (ISMMS). Dr Feder is named co-inventor on an issued patent in the US, and several issued patents outside the US, filed by ISMMS for the use of ketamine as a therapy for PTSD; this intellectual property has not been licensed. Drs Feingold, Peccoralo, and Ripp report no relevant financial relationships. Funding/support: This study was supported by internal funding devoted to COVID-19–related projects from the Icahn School of Medicine at Mount Sinai. Preparation of this report was supported in part by the US Department of Veterans Affairs National Center for Posttraumatic Stress Disorder (Dr Pietrzak). Dr Feingold was funded by TL1 grant TR001434. Role of the sponsor: The funders had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; or decision to submit the manuscript for publication. Acknowledgments: The authors thank all the participants at Mount Sinai Hospital who participated in this study. They also acknowledge the COVID-19 Psychological Impact Study Team for their contributions to this project: Chi C. Chan, PhD; Carly A. Kaplan, BS; Halley Kaye-Kauderer, BA; Jaclyn Verity, MPH; Larissa Burka, RN; Alicia Hurtado, MD; and James W. Murrough, MD, PhD. The acknowledged individuals have no relevant financial relationships to disclose. Supplementary material: See accompanying pages.

PY - 2022

Y1 - 2022

UR - http://www.scopus.com/inward/record.url?scp=85139570480&partnerID=8YFLogxK

U2 - 10.4088/PCC.22br03342

DO - 10.4088/PCC.22br03342

M3 - Comment/debate

C2 - 36206372

AN - SCOPUS:85139570480

SN - 1523-5998

VL - 24

JO - The primary care companion for CNS disorders

JF - The primary care companion for CNS disorders

IS - 5

M1 - 22br03342

ER -